← FDA Drug Approvals (Drugs@FDA)
BORTEZOMIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCINOPHARM TAIWAN · Approved 2023-09-26
Drug application
- FDA Application #
ANDA216912- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BORTEZOMIB
- Generic name
- Bortezomib
- Active ingredients
- BORTEZOMIB
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- SCINOPHARM TAIWAN
- First approval
- 2023-09-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown